Hormonal strategy for the primary or secondary treatment of endometriosis

Lucia Lazzeri, Claudia Tosti, Serena Pinzauti, Cinzia Orlandini, Stefano Luisi, Felice Petraglia
In: Expert Review of Obstetrics & Gynecology · 2012 · vol. 7(5) , pp. 467–476 · doi:10.1586/eog.12.46 · W2108007286
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Hormonal therapies for endometriosis, including iatrogenic menopause and pseudopregnancy strategies, aim to inhibit ovulation and suppress ectopic implants to reduce pain and inflammation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic inflammatory disease characterized by dysmenorrhea, dyspareunia and infertility, which may be treated surgically and/or medically. The medical treatment of endometriosis may be used as a first-line option, as an alternative to surgery and for postoperative adjuvant use. The most commonly used drugs are hormones, which act via two major strategies: iatrogenic menopause and pseudopregnancy. In both cases, the goal is to create a steady hormonal environment with inhibition of ovulation, suppressing the ectopic implants and reducing the inflammatory status as well as the associated pain symptoms. The blockade of the growth and activity of endometriotic lesions is obtained, and long-term or repeated courses of medication may be required to control symptoms. To obtain reduced ovarian activity, gonadotropin-releasing hormone analogs, gonadotropin-releasing hormone analog antagonists or aromatase inhibitors are currently used or are under investigation. Pseudopregnancy is obtained by the use of progestins or oral estroprogestins; based on their favorable safety profile, tolerability and cost, they should be considered as primary intervention. The future perspective is to use a multiple approach for treating women with endometriosis with the goal of eradicating the disease and eliminating the symptoms.

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrheadyspareuniainfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (80)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK